Table 2.
Comparison of characteristics in patients with EIA IgM+/IgG− who had serology performed for evaluation of symptoms versus screening
| Characteristic | No. (%) of patients who had serology fora: |
P value | |
|---|---|---|---|
| Evaluation of symptoms (n = 60) | Screening (n = 29) | ||
| Demographics | |||
| Age, median (range), yr | 55 (24–82) | 52 (16–69) | 0.11 |
| White race | 31 (52) | 13 (45) | 0.65 |
| Strength of diagnosis: confirmed, highly probable, or probable | 54 (90) | 13 (45) | <0.001 |
| Comorbid conditions | |||
| Tobacco use | 25 (42) | 12 (41) | >0.99 |
| Diabetes mellitus | 8 (13) | 10 (34) | 0.03 |
| Transplant | 2 (3) | 5 (17) | 0.03 |
| Pulmonary disease | 6 (10) | 1 (3) | 0.42 |
| Immunosuppression | 11 (18) | 9 (31) | 0.19 |
| HIV infection | 0 | 0 | >0.99 |
| Characteristics of coccidioidomycosis | |||
| Pulmonary infection | 50 (83) | 7 (24) | <0.001 |
| Extrapulmonary infection | 2 (3) | 0 | >0.99 |
| Abnormal imaging | 50 (83) | 6 (21) | <0.001 |
| Treated with antifungal agent | 41 (68) | 5 (17) | 0.001 |
a
Patients with prior abnormal results were omitted. Values are numbers (percentages) unless indicated otherwise.